| Date Filed | Type | Description |
| 06/09/2023 |
4
| Hamill Laura (Director) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 2,330 shares
@ $0
Granted 13,950 options to buy
@ $8.13, valued at
$113.4k
|
|
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2023 |
4
| Hamill Laura (Director) has filed a Form 4 on ANAPTYSBIO, INC|
Txns:
| Granted 10,600 options to buy
@ $23.23, valued at
$246.2k
Granted 3,900 restricted stock units
@ $0 |
|
| 11/15/2022 |
3
| Hamill Laura (Director) has filed a Form 3 on Vickers Vantage Corp. I |
| 07/19/2022 |
4
| Hamill Laura (Director) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 16,000 options to buy
@ $16.64, valued at
$266.2k
|
|
| 06/10/2022 |
4
| Hamill Laura (Director) has filed a Form 4 on PARDES BIOSCIENCES, INC.|
Txns:
| Granted 37,500 options to buy
@ $5.21, valued at
$195.4k
|
|
| 02/14/2022 |
4
| Hamill Laura (Director) has filed a Form 4 on ANAPTYSBIO, INC|
Txns:
| Granted 9,200 options to buy
@ $30.44, valued at
$280k
|
|
| 12/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/27/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/22/2021 |
4
| Hamill Laura (Director) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Unknown transaction of 474 shares
@ $0
Disposed/sold 9,339 options to buy
@ $101.88, valued at
$951.5k
Disposed/sold 941 options to buy
@ $115.53, valued at
$108.7k
|
|
| 06/14/2021 |
4
| Hamill Laura (Director) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 16,000 options to buy
@ $37.53, valued at
$600.5k
|
|
| 02/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/17/2020 |
4
| Hamill Laura (Director) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Granted 9,339 options to buy
@ $101.88, valued at
$951.5k
|
|
| 09/17/2020 |
3
| Hamill Laura (Director) has filed a Form 3 on ACCELERON PHARMA INC |
| 06/24/2020 |
4
| Hamill Laura (Director) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 32,000 options to buy
@ $48.67, valued at
$1.6M
|
|
| 06/18/2020 |
3
| Hamill Laura (Director) has filed a Form 3 on Y-mAbs Therapeutics, Inc. |
| 02/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/26/2019 |
4
| Hamill Laura (Director) has filed a Form 4 on ANAPTYSBIO, INC|
Txns:
| Granted 6,000 options to buy
@ $38.47, valued at
$230.8k
Granted 2,268 options to buy
@ $38.47, valued at
$87.2k
|
|
| 09/26/2019 |
3
| Hamill Laura (Director) has filed a Form 3 on ANAPTYSBIO, INC |
| 05/10/2019 |
4
| Hamill Laura (EVP, Worldwide Commercial Ops) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Granted 9,840 shares
@ $0
Paid exercise price by delivering 3,500 shares
@ $66.07, valued at
$231.2k
|
|
| 02/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/09/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/18/2018 |
3
| Hamill Laura (EVP, Worldwide Commercial Ops) has filed a Form 3 on GILEAD SCIENCES INC |